Yes. We'd love to see that included in a future analysis. Thank you.
Forgive me for perhaps not understanding the part about economy-wide savings as well as I should, but maybe I'm representing Canadians to some extent as well.
You say that drug expenditures in Canada would be reduced by having a single payer due to a few factors, including increasing negotiating power. Could you just comment on or give me a bit more explanation on what you mean by “economy-wide savings”?